ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) will present a company overview during the H.C. Wainwright 25th Annual Global Investment Conference on September 13. CEO Chris Xu will also host one-on-one meetings during the event.

Positive

• ThermoGenesis will present a company overview at the H.C. Wainwright conference, which could generate investor interest and potentially positively impact the stock price.

Negative

• None.

RANCHO CORDOVA, Calif., Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET, during the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023, in New York. 

Dr. Xu will also host in-person and virtual one-on-one meetings during the event. Institutional investors who are registered for the conference can log into www.hcwevents.com to request a meeting with the company. Those interested in meeting with Dr. Xu outside of the conference should contact Michael Miller at mmiller@rxir.com.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Contact Information

Company Contact:
Wendy Samford
916-858-5191
ir@thermogenesis.com

Investor Relations Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

View original content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-present-at-the-hc-wainwright-25th-annual-global-investment-conference-301918883.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis present at the H.C. Wainwright conference?

ThermoGenesis will present on September 13.

Who will present the company overview?

CEO Chris Xu will present the company overview.

Will there be one-on-one meetings during the event?

Yes, CEO Chris Xu will host one-on-one meetings during the event.

How can institutional investors request a meeting with the company?

Institutional investors registered for the conference can log into www.hcwevents.com to request a meeting with the company.

How can someone interested in meeting with Dr. Xu outside of the conference contact him?

They can contact Michael Miller at mmiller@rxir.com.